| Literature DB >> 36203147 |
Miao Wang1,2, Tianze Liu1, Changli Xu1, Chang Liu3,4, Bo Li1, Qiujian Lian1, Tongjiang Chen1, Suchi Qiao5, Zhiwei Wang6.
Abstract
BACKGROUND: Limb salvage reconstruction for pelvic tumors, especially periacetabular tumors, is challenging. We combined the use of dual mobility bearing and 3D-printed hemipelvic prosthesis to improve function and reduce the probability of complications after hemi-pelvic resection in patients with primary acetabular malignancy. The purpose of this study was to evaluate the efficacy and safety of this combination.Entities:
Keywords: Bone neoplasm; Dual mobility; Finite element analysis; Pelvic; Prosthesis design
Mesh:
Substances:
Year: 2022 PMID: 36203147 PMCID: PMC9541076 DOI: 10.1186/s12893-022-01804-8
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Fig. 1Preoperative planning for patient 11, a 42-year-old female with left pelvic chondrosarcoma. A–C Radiograph and magnetic resonance imaging scans showing tumor involvement in pelvic regions I and II. D–F Computer simulated tumor resection and reconstruction. G, H 3D‐printed 1:1 ratio lesion model and osteotomy. I Image of a dual mobility bearing
Fig. 2Surgical resection and implantation procedure. A Preoperative tumor vascular embolization. B Customized osteotomy template. C 3D-printed hemipelvic prosthesis. D Intraoperative osteotomy performed with the aid of the customized osteotomy template. E Implantation of the 3D-printed hemipelvic prosthesis. The reconstructed joint did not dislocate even in an extreme position. F Suturing of the surrounding soft tissue. G, H Comparison of the intact hemipelvic bone and the 3D-printed hemipelvic prosthesis. I Radiograph obtained 6 months after the procedure
Demographic and clinical characteristics and follow-up results of patients who underwent reconstruction following tumor resection
| Case no | Age, year | Sex | Follow-up, months | Diagnosis | Staginga | Resection typeb | Blood loss, mL | Operation time, hours | Status | Outcome | Painc | Functionc | Emotional acceptancec | Supportc | Walking abilityc | Gaitc | Total score (%)c |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 34 | F | 12 | Ewing sarcoma | IIB | I + II + III | 3500 | 10 | dec | Local recurrence and distant metastasis (lung) | NA | NA | NA | NA | NA | NA | NA |
| 2 | 54 | F | 50 | Chondrosarcoma | IIB | II | 4500 | 9 | ned | Intact reconstruction | 5 | 4 | 5 | 3 | 3 | 3 | 23 (76.7) |
| 3 | 43 | M | 44 | Chondrosarcoma | IIB | II + III | 6000 | 9 | ned | Intact reconstruction | 4 | 3 | 4 | 3 | 3 | 3 | 20 (66.7) |
| 4 | 24 | M | 4 | Osteosarcoma | IIB | II + III | 3000 | 6 | dec | Complications of chemotherapy | NA | NA | NA | NA | NA | NA | NA |
| 5 | 56 | M | 40 | Chondrosarcoma | IIB | I + II | 3000 | 8 | ned | Intact reconstruction | 4 | 4 | 5 | 4 | 4 | 4 | 25 (83.3) |
| 6 | 27 | F | 36 | Ewing sarcoma | IIB | I + II + III | 3500 | 6.5 | ned | Intact reconstruction | 3 | 3 | 4 | 3 | 3 | 3 | 19 (63.3) |
| 7 | 57 | M | 30 | Osteosarcoma | IIB | I + II + III | 3000 | 6 | ned | Amputation for local recurrence | NA | NA | NA | NA | NA | NA | NA |
| 8 | 53 | M | 24 | Fibrosarcoma | IIB | I + II | 3000 | 4.5 | ned | Repeated dislocation | 3 | 3 | 4 | 3 | 3 | 2 | 18 (60) |
| 9 | 41 | F | 22 | Giant cell tumor | IIA | II | 1500 | 4.5 | ned | Intact reconstruction | 4 | 4 | 5 | 4 | 4 | 4 | 25 (83.3) |
| 10 | 63 | M | 14 | Chondrosarcoma | IIA | II | 2000 | 5.5 | ned | Intact reconstruction | 4 | 3 | 4 | 3 | 3 | 3 | 20 (66.7) |
| 11 | 43 | F | 10 | Chondrosarcoma | IIA | II | 1500 | 4 | ned | Intact reconstruction | 4 | 3 | 5 | 3 | 3 | 3 | 21 (70) |
F female, M male, dec deceased, ned no evidence of disease, NA not assessed
aStaging according to the Enneking system
bResection type indicates pelvic regions involved
cThe Musculoskeletal Tumor Society 93 scoring system was used for evaluating postoperative function; each of the six variables was assessed on a 5-point scale, with a maximum total score of 30
Fig. 3Radiograph images of a patient with recurrent dislocation. A Radiograph image obtained before the open reduction. B Radiograph image obtained after the reduction. C Radiograph image obtained before placement of the polyethylene liner and femoral head. D Radiograph image obtained after placement of polyethylene liner and femoral head
Fig. 4Distribution of the stress in the postoperative pelvis and hip joint at different phases of the gait. A Heel on the ground. B Toe on the ground. C Midstance. D Heel off the ground. E Toe off the ground
Distribution of stress in the postoperative pelvis and hip joint at different phases of gait (MPa)
| Cortical bone of affected side pelvis | Cortical bone of unaffected side pelvis | Hemipelvic prosthesis | Screws | Polyethylene liner | Femoral prosthesis | |
|---|---|---|---|---|---|---|
| Heel to the ground | 40.9 | 38.2 | 19.9 | 17.2 | 8.5 | 43.5 |
| Toe to the ground | 55.6 | 33.3 | 21.0 | 30.5 | 10.9 | 64.1 |
| Midstance | 50.2 | 46.8 | 21.2 | 28.6 | 5.1 | 44.4 |
| Heel off the ground | 73.3 | 44.0 | 24.8 | 34.3 | 6.6 | 70.0 |
| Toe off the ground | 68.8 | 41.3 | 25.5 | 32.0 | 5.8 | 67.1 |
Fig. 5Comparison of cortical bone stress on the affected side vs the contralateral side at different gait phases
Fig. 6Distribution of stress across various components of the prosthesis during different phases of the gait
Fig. 7Distribution of stress in the hemipelvic prosthesis and dual mobility bearing at three different angles with a joint compressive force of 2000 N. A 0°; B 30°; C 65°
Studies reporting hip reconstruction using a custom-made prosthesis or a prothesis with a dual mobility bearing
| Study | Prosthesis | No. of patients | Follow-up duration, mean (range) | Functional outcome, mean MSTS-93 score (of 30 points maximum) | No. of patients with hip dislocation after procedure | Other complications (No. of patients) |
|---|---|---|---|---|---|---|
| Current study | 3D Custom-made (with dual mobility bearing) | 11 | 30 (10–50) months | 21.4 | 1 of 11 | Infection (1 of 11) |
| Wu [ | 3D Custom-made | 28 | 32.2 (3–75) months | 23 | 3 of 28 | Superficial infection (6 of 28) |
| Peng [ | 3D Custom-made | 5 | 30.3 (18–42) months | 19.8 | 0 of 5 | 0 of 5 |
| Wang [ | 3D Custom-made | 13 | 27 (24–31) months | 23 | 0 of 13 | Delayed wound healing (2 of 13) |
| Holzapfel [ | Custom-made | 56 | 66 (1–270) months | 18.4 | 11 of 56 | Infection (14 of 56), delayed wound healing (10 of 56), loosening (3 of 56) |
| Sun [ | Custom-made | 16 | 36 (23–62) months | 21.6 | 3 of 16 | Delayed wound healing (6 of 16), prosthesis breakage (4 of 16), deep infection (1 of 16) |
| Guo [ | Custom-made | 18 | 41 (7–73) months | 21.5 | 2 of 18 | Delayed wound healing (2 of 18), deep vein thrombosis (1 of 18), loosening (1 of 18) and sciatic nerve palsy (1 of 18) |
| Jiaswal [ | Custom-made | 98 | 65 (2–33.5) months | Mean TESS score 17.8 of 30 | 19 of 98 | Infection (30 of 98), loosening (3 of 98)and deep-vein thrombosis(7 of 98) |
| Dai [ | 3D Custom-made | 10 | 34 (21–48) months | 70% Good function | 2 of 10 | Deep infection (3 of 10), aseptic loosening (1 of 10) |
| Ozaki [ | Custom-made | 12 | 57 (26–77) months | Mean MSTS-87 score 11 of 30 | 1 of 12 | Deep infection (3 of 12), loosening (3 of 12) and recurrence (4 of 12) |
| Abudu [ | Custom-made | 35 | 34 (12–312) months | 21 | 6 of 35 | Deep infection (9 of 35), aseptic loosening (2 of 35) and thromboembolism (1 of 35) |
| Bus [ | Pedestal cup endoprosthesis; 24 with dual mobility cups | 47 | Minimum 24 months | 21 | 10 of 47 (dual mobility cups, 1 of 24) | Deep infection (13 of 47), loosening (3 of 47) |
| Philippeau [ | Dual mobility acetabular cups | 71 (33 primary tumor, 38 with metastasis) | Primary, 3.3 years (0.6–7.1; metastasis, 1.25 years (0.2–7.9) | Metastasis, 20.4; Primary, 17.9 | 7 of 71 | Deep infection (7 of 71), loosening (4 of 71) |
MSTS-93 Musculoskeletal Tumor Society 93, TESS Toronto Extremity Salvage Score